Proportion of Patients With AD, DLB and PDD Treated With Anti-Dementia Drugs

Identifying Attributes

Care Settings

Dementia Care

Country

Denmark

Publishing Organisation

Danish National Dementia Clinical Quality Database

Type of Quality Indicator

Process

IOM Quality Dimension

Effectiveness

Domain

Interventions to Promote Cognition, Independence and Wellbeing

Defining Attributes

Definition

Proportion of patients with AD, DLB and PDD treated with anti-dementia drugs

Numerator

Number of patients with Alzheimer's dementia, dementia with Lewy bodies; Parkinson's disease dementia treated with anti-dementia drugs

Denominator

Number of patients with Alzheimer's dementia, dementia with Lewy bodies; Parkinson's disease dementia

Exclusions

Patients seen for presymptomatic genetic evaluation are excluded

Use of Risk Adjustment

Risk Adjustments

Stratifications

Collection and Reporting Attributes

Type of Data Collection

Standardised clinical data

Data Collection Methods

Data entered by participating units into an Internet-based IT platform

Frequency of Data Collection

Continuous

Frequency of Data Collection in Days

Reporting Methods

Yearly report

Reporting Frequency

Annually

Reporting Frequency in Days

365

Indicator Has Recommended Targets

Yes

Source and Reference Attributes

Evidence Source

Peter Johannsen , Kasper Jørgensen , Alex Kørner , Elisabeth G. Elmo , Lene B. Lauesen & Jan Utzon (2011) Development of a dementia assessment quality database, Aging & Mental Health, 15:1, 40-46, DOI: 10.1080/13607863.2010.508776

Technical Specifications

Link to Measurement Tools

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022

Yes